Technical Analysis for VBLT - Vascular Biogenics Ltd.

Grade Last Price % Change Price Change
C 1.98 2.06% 0.04
VBLT closed up 2.06 percent on Friday, May 14, 2021, on 23 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down
Historical VBLT trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Outside Day Range Expansion 0.00%
20 DMA Resistance Bearish 2.06%
50 DMA Resistance Bearish 2.06%
MACD Bearish Signal Line Cross Bearish 2.06%
Earnings Movers Other 2.06%
Inside Day Range Contraction 2.06%
Fell Below 20 DMA Bearish 2.06%
Fell Below 50 DMA Bearish 2.06%
Older End-of-Day Signals for VBLT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Vascular Biogenics Ltd. Description

Vascular Biogenics Ltd., a clinical-stage biopharmaceutical company, is engaged in the discovery, development, and commercialization of treatments for cancer and immune-inflammatory diseases. Its lead product candidates include VB-111, a gene-based biologic, which is in Phase II clinical trials for the treatment of recurrent glioblastoma, an aggressive form of brain cancer; in Phase II clinical trials to treat thyroid cancer; and in Phase I/II clinical trials for the treatment of ovarian cancer, as well as VB-201, an oral small molecule that is in Phase II clinical trials for the treatment psoriasis and ulcerative colitis. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was founded in 2000 and is headquartered in Or Yehuda, Israel.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Cancer Pharmaceutical Industry Autoimmune Diseases Clinical Trial Ovarian Cancer Inflammatory Disease Inflammatory Diseases Blastoma Thyroid Psoriasis Glioblastoma Ulcer Colitis Ulcerative Colitis Brain Cancer Treatment Of Ovarian Cancer Thyroid Cancer Immune Inflammatory Diseases Recurrent Glioblastoma

Is VBLT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 3.17
52 Week Low 1.01
Average Volume 495,671
200-Day Moving Average 1.69
50-Day Moving Average 1.96
20-Day Moving Average 1.98
10-Day Moving Average 2.02
Average True Range 0.16
ADX 23.17
+DI 18.23
-DI 14.70
Chandelier Exit (Long, 3 ATRs ) 1.83
Chandelier Exit (Short, 3 ATRs ) 2.16
Upper Bollinger Band 2.22
Lower Bollinger Band 1.74
Percent B (%b) 0.5
BandWidth 24.33
MACD Line 0.01
MACD Signal Line 0.02
MACD Histogram -0.0056
Fundamentals Value
Market Cap 94.84 Million
Num Shares 47.9 Million
EPS -0.50
Price-to-Earnings (P/E) Ratio -3.93
Price-to-Sales 65.08
Price-to-Book 1.74
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.19
Resistance 3 (R3) 2.19 2.13 2.16
Resistance 2 (R2) 2.13 2.07 2.13 2.14
Resistance 1 (R1) 2.05 2.04 2.09 2.05 2.13
Pivot Point 1.99 1.99 2.01 1.99 1.99
Support 1 (S1) 1.91 1.93 1.95 1.91 1.83
Support 2 (S2) 1.85 1.90 1.85 1.82
Support 3 (S3) 1.77 1.85 1.81
Support 4 (S4) 1.77